Jennifer A. Amrhein
Frankfurt Am Main, HE 60438, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Un-LOK-ing a New Approach for Conformational Selective Targeting of STK10 (LOK).
Journal: ACS medicinal chemistry letters
Published: August 06, 2025
Development of pyrazolo[1,5-a]pyrimidine based macrocyclic kinase inhibitors targeting AAK1.
Journal: European journal of medicinal chemistry
Published: April 07, 2025
Synthesis of Pyrazole-Based Macrocycles Leads to a Highly Selective Inhibitor for MST3.
Journal: Journal of medicinal chemistry
Published: December 21, 2023
Design and Synthesis of Pyrazole-Based Macrocyclic Kinase Inhibitors Targeting BMPR2.
Journal: ACS medicinal chemistry letters
Published: April 11, 2023
Macrocyclization of Quinazoline-Based EGFR Inhibitors Leads to Exclusive Mutant Selectivity for EGFR L858R and Del19.
Journal: Journal of medicinal chemistry
Published: November 16, 2022
Discovery of 3-Amino-1H-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family.
Journal: International journal of molecular sciences
Published: November 10, 2022
Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5-a]pyrimidine-Based Macrocycles.
Journal: Journal of medicinal chemistry
Published: May 24, 2022
Synthetic Opportunities and Challenges for Macrocyclic Kinase Inhibitors.
Journal: Journal of medicinal chemistry
Published: June 02, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026